Obesity reprograms the normal pancreas and pancreatic cancer microbiome in mice and humans
IntroductionPancreatic ductal adenocarcinoma (PDAC) is an aggressive form of pancreatic cancer, with overall 5-year survival rates of about 8%. Obesity (and underlying metabolic dysfunction) is estimated to account for up to 50% of all PDACs. Microbial communities can be modulated by obesity and exe...
Saved in:
| Main Authors: | Raquel Santana da Cruz, Shravanthy Suguru, Sara P. C. Paiva, Ijeoma Nwugwo, Bhaskar Kallakury, Benjamin A. Weinberg, Katherine L. Cook, Sonia de Assis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Microbiomes |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/frmbi.2025.1543144/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Most oncological pancreas resections must consider the mesopancreas
by: S. A. Safi, et al.
Published: (2025-02-01) -
Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
by: Yuan Fang, et al.
Published: (2024-11-01) -
Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model
by: Joanna Napp, et al.
Published: (2024-12-01) -
Commentary: An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images
by: Jiandong Cao, et al.
Published: (2025-04-01) -
Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer
by: Qi-Wen Wang, et al.
Published: (2025-03-01)